| Factors | Group A (n = 24) | Group B (n = 26) | P value |
| Male/Female | 16/8 | 18/8 | ns |
| Age (years) | 66.8 (40 - 79) | 64.2 (33 - 78) | ns |
| Depth of cancer invasion |
|
|
|
| Mucosa | 79.2% (19/24) | 76.9% (20/26) | ns |
| Submucosa | 21.8% (5/24 | 23.1% (6/10) |
|
| Lymph node metastasis |
|
|
|
| No | 100% (24/24) | 100% (26/26) |
|
| Pathological stage |
|
|
|
| Stage IA | 100% (24/24) | 100% (26/26) |
|
| Lymphnode resection |
|
|
|
| D1 | 79.2% (19/24) | 80.8% (21/26) | ns |
| D1 + α | 20.8% (5/24) | 19.2% (5/26) |
|
| PHCV preservation |
|
|
|
| Preservation | 100% (24/24) | 100% (26/26) |
|
| No preservation | 0% (0/24) | 0% (0/26) |
|
| Resected stomach |
|
|
|
| 1/3 | 100% (12/12) | 100% (10/10) |
|
| Length of antral cuff (cm) |
|
|
|
| 2.0 ± 0.4 3.0 ± 0.3 < 0.01 |
|
|
|
| Past history |
|
|
|
| No | 100% (24/24) | 100% (26/26) |
|
| Postoperative complications |
|
|
|
| Wound infection | 4.2% (1/24) | 7.7% (2/26) | ns |
| Postoperative chemotherapy |
|
|
|
| No | 100% (24/24 | 100% (26/26) |
|